Conmed (CNMD) FCF Payout Ratio Growth (3y) (2015 - 2025)
Conmed (CNMD) FCF Payout Ratio Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.91% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -3.43% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.06% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Conmed | 1.29 Bn | 1.26 Bn | 183.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.36% |
| Sep 30, 2025 | -26.21% |
| Jun 30, 2025 | -16.42% |
| Mar 31, 2025 | 27.93% |
| Dec 31, 2024 | -6.26% |
| Sep 30, 2024 | -29.58% |
| Jun 30, 2024 | -5.85% |
| Mar 31, 2024 | -8.88% |
| Dec 31, 2023 | -29.22% |
| Sep 30, 2023 | -5.61% |
| Jun 30, 2023 | -55.78% |
| Mar 31, 2023 | -28.44% |
| Dec 31, 2022 | -60.79% |
| Sep 30, 2022 | 21.22% |
| Jun 30, 2022 | 10.00% |
| Mar 31, 2022 | -35.15% |
| Dec 31, 2021 | -12.20% |
| Sep 30, 2021 | 26.14% |
| Jun 30, 2021 | -17.22% |
| Mar 31, 2021 | 4.47% |